{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:44Z","timestamp":1778902004800,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.cardfail.2014.05.012","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T16:45:42Z","timestamp":1401900342000},"page":"555-559","source":"Crossref","is-referenced-by-count":38,"title":["Trastuzumab-Induced Cardiomyopathy: Incidence and Associated Risk Factors in an Inner-City Population"],"prefix":"10.1016","volume":"20","author":[{"given":"Kaitlin B.","family":"Baron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine H.R.","family":"Tkaczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen S.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2014.05.012_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.11-90001-4","article-title":"Adjuvant trastuzumab: a milestone in the treatment of HER-2 positive early breast cancer","volume":"11","author":"Baselga","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.cardfail.2014.05.012_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab\u2014mechanism of action and use in clinical practice","volume":"357","author":"Hudis","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2014.05.012_bib3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s12325-009-0048-z","article-title":"Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer","volume":"26","author":"Fiuza","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.cardfail.2014.05.012_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/FJC.0b013e3181e0f89a","article-title":"Cancer therapy\u2013associated cardiotoxicity and signaling in the myocardium","volume":"56","author":"Zuppinger","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2014.05.012_bib5","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2007.11.0106","article-title":"Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility","volume":"25","author":"Telli","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cardfail.2014.05.012_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant Trastuzumab in HER 2\u2013positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2014.05.012_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfr165","article-title":"Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge","volume":"14","author":"Tocchetti","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2014.05.012_bib8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11886-012-0256-z","article-title":"Early detection of chemotherapy-related left ventricular dysfunction","volume":"14","author":"Decera","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cardfail.2014.05.012_bib9","series-title":"Herceptin [trastuzumab]: highlights of prescribing information","year":"1998"},{"key":"10.1016\/j.cardfail.2014.05.012_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-7-153","article-title":"Adjuvant trastuzumab in the treatment of HER-2\u2013positive early breast cancer: a meta-analysis of published randomized trials","volume":"7","author":"Viani","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cardfail.2014.05.012_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-007-9663-z","article-title":"Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials","volume":"109","author":"Bria","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cardfail.2014.05.012_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2011.10.015","article-title":"Trastuzumab adjuvant chemotherapy and cardiotoxcity in real-world women with breast cancer","volume":"18","author":"Tarantini","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.012_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cardfail.2009.04.011","article-title":"Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study","volume":"15","author":"Guglin","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2014.05.012_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/CAD.0b013e3283394624","article-title":"Anticancer therapy induced cardiotoxicity: review of the literature","volume":"21","author":"Geiger","year":"2010","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.cardfail.2014.05.012_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbrc.2011.06.169","article-title":"Herceptin, a recombinant humanized anti-ERB2 monoclonal antibody, induces cardiomyocyte death","volume":"411","author":"Singh","year":"2011","journal-title":"Biochem Biophysical Res Commun"},{"key":"10.1016\/j.cardfail.2014.05.012_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/cncr.10854","article-title":"Trastuzumab-associated cardiotoxicity","volume":"95","author":"Keefe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cardfail.2014.05.012_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/14740331003627441","article-title":"The cardiac safety of trastuzumab in the treatment of breast cancer","volume":"9","author":"Chien","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cardfail.2014.05.012_bib18","unstructured":"Surveillance, Epidemiology and End Results Program. Breast cancer. Fact sheet. Available at: http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed December 4,\u00a02013."},{"key":"10.1016\/j.cardfail.2014.05.012_bib19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/theoncologist.2013-0243","article-title":"Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research","volume":"18","author":"Wheeler","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.cardfail.2014.05.012_bib20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.294.14.1765","article-title":"Comorbidity and survival disparities among black and white patients with breast cancer","volume":"294","author":"Tammemagi","year":"2005","journal-title":"JAMA"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916414002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T16:58:28Z","timestamp":1538585908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916414002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1071916414002176"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2014.05.012","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}